These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 30105502)

  • 1. Neurofilament light chain in blood is negatively associated with neuropsychological performance in HIV-infected adults and declines with initiation of antiretroviral therapy.
    Anderson AM; Easley KA; Kasher N; Franklin D; Heaton RK; Zetterberg H; Blennow K; Gisslen M; Letendre SL
    J Neurovirol; 2018 Dec; 24(6):695-701. PubMed ID: 30105502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebrospinal fluid interferon alpha levels correlate with neurocognitive impairment in ambulatory HIV-Infected individuals.
    Anderson AM; Lennox JL; Mulligan MM; Loring DW; Zetterberg H; Blennow K; Kessing C; Koneru R; Easley K; Tyor WR
    J Neurovirol; 2017 Feb; 23(1):106-112. PubMed ID: 27400930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic and prognostic biomarkers for HAND.
    McLaurin KA; Booze RM; Mactutus CF
    J Neurovirol; 2019 Oct; 25(5):686-701. PubMed ID: 30607890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High efavirenz levels but not neurofilament light plasma levels are associated with poor neurocognitive functioning in asymptomatic HIV patients.
    Hakkers CS; Hermans AM; van Maarseveen EM; Teunissen CE; Verberk IMW; Arends JE; Hoepelman AIM
    J Neurovirol; 2020 Aug; 26(4):572-580. PubMed ID: 32524424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebrospinal fluid extracellular vesicles and neurofilament light protein as biomarkers of central nervous system injury in HIV-infected patients on antiretroviral therapy.
    Guha D; Mukerji SS; Chettimada S; Misra V; Lorenz DR; Morgello S; Gabuzda D
    AIDS; 2019 Mar; 33(4):615-625. PubMed ID: 30557159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive and Neuronal Link With Inflammation: A Longitudinal Study in People With and Without HIV Infection.
    Anderson AM; Jang JH; Easley KA; Fuchs D; Gisslen M; Zetterberg H; Blennow K; Ellis RJ; Franklin D; Heaton RK; Grant I; Letendre SL
    J Acquir Immune Defic Syndr; 2020 Dec; 85(5):617-625. PubMed ID: 32932412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma Concentration of the Neurofilament Light Protein (NFL) is a Biomarker of CNS Injury in HIV Infection: A Cross-Sectional Study.
    Gisslén M; Price RW; Andreasson U; Norgren N; Nilsson S; Hagberg L; Fuchs D; Spudich S; Blennow K; Zetterberg H
    EBioMedicine; 2016 Jan; 3():135-140. PubMed ID: 26870824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiretroviral treatment reduces increased CSF neurofilament protein (NFL) in HIV-1 infection.
    Mellgren A; Price RW; Hagberg L; Rosengren L; Brew BJ; Gisslén M
    Neurology; 2007 Oct; 69(15):1536-41. PubMed ID: 17923616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Central and peripheral markers of neurodegeneration and monocyte activation in HIV-associated neurocognitive disorders.
    McGuire JL; Gill AJ; Douglas SD; Kolson DL;
    J Neurovirol; 2015 Aug; 21(4):439-48. PubMed ID: 25776526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma neuronal exosomes serve as biomarkers of cognitive impairment in HIV infection and Alzheimer's disease.
    Pulliam L; Sun B; Mustapic M; Chawla S; Kapogiannis D
    J Neurovirol; 2019 Oct; 25(5):702-709. PubMed ID: 30610738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation between cerebrospinal fluid and plasma neurofilament light protein in treated HIV infection: results from the COBRA study.
    Alagaratnam J; De Francesco D; Zetterberg H; Heslegrave A; Toombs J; Kootstra NA; Underwood J; Gisslen M; Reiss P; Fidler S; Sabin CA; Winston A
    J Neurovirol; 2022 Feb; 28(1):54-63. PubMed ID: 34874540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment intensification with maraviroc (CCR5 antagonist) leads to declines in CD16-expressing monocytes in cART-suppressed chronic HIV-infected subjects and is associated with improvements in neurocognitive test performance: implications for HIV-associated neurocognitive disease (HAND).
    Ndhlovu LC; Umaki T; Chew GM; Chow DC; Agsalda M; Kallianpur KJ; Paul R; Zhang G; Ho E; Hanks N; Nakamoto B; Shiramizu BT; Shikuma CM
    J Neurovirol; 2014 Dec; 20(6):571-82. PubMed ID: 25227930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum neurofilament light chain in genetic frontotemporal dementia: a longitudinal, multicentre cohort study.
    van der Ende EL; Meeter LH; Poos JM; Panman JL; Jiskoot LC; Dopper EGP; Papma JM; de Jong FJ; Verberk IMW; Teunissen C; Rizopoulos D; Heller C; Convery RS; Moore KM; Bocchetta M; Neason M; Cash DM; Borroni B; Galimberti D; Sanchez-Valle R; Laforce R; Moreno F; Synofzik M; Graff C; Masellis M; Carmela Tartaglia M; Rowe JB; Vandenberghe R; Finger E; Tagliavini F; de Mendonça A; Santana I; Butler C; Ducharme S; Gerhard A; Danek A; Levin J; Otto M; Frisoni GB; Cappa S; Pijnenburg YAL; Rohrer JD; van Swieten JC;
    Lancet Neurol; 2019 Dec; 18(12):1103-1111. PubMed ID: 31701893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biomarker evidence of axonal injury in neuroasymptomatic HIV-1 patients.
    Jessen Krut J; Mellberg T; Price RW; Hagberg L; Fuchs D; Rosengren L; Nilsson S; Zetterberg H; Gisslén M
    PLoS One; 2014; 9(2):e88591. PubMed ID: 24523921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased Intrathecal Immune Activation in Virally Suppressed HIV-1 Infected Patients with Neurocognitive Impairment.
    Edén A; Marcotte TD; Heaton RK; Nilsson S; Zetterberg H; Fuchs D; Franklin D; Price RW; Grant I; Letendre SL; Gisslén M
    PLoS One; 2016; 11(6):e0157160. PubMed ID: 27295036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Plasma Neurofilament Light Chain with Neocortical Amyloid-β Load and Cognitive Performance in Cognitively Normal Elderly Participants.
    Chatterjee P; Goozee K; Sohrabi HR; Shen K; Shah T; Asih PR; Dave P; ManYan C; Taddei K; Chung R; Zetterberg H; Blennow K; Martins RN
    J Alzheimers Dis; 2018; 63(2):479-487. PubMed ID: 29630554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association Between Longitudinal Plasma Neurofilament Light and Neurodegeneration in Patients With Alzheimer Disease.
    Mattsson N; Cullen NC; Andreasson U; Zetterberg H; Blennow K
    JAMA Neurol; 2019 Jul; 76(7):791-799. PubMed ID: 31009028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationships between plasma neurofilament light chain protein, cognition, and brain aging in people with HIV.
    Cooley SA; Petersen KJ; Tice C; Langford D; Burdo TH; Roman J; Ances BM
    AIDS; 2024 Jun; 38(7):955-962. PubMed ID: 38329137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma tau, neurofilament light chain and amyloid-β levels and risk of dementia; a population-based cohort study.
    de Wolf F; Ghanbari M; Licher S; McRae-McKee K; Gras L; Weverling GJ; Wermeling P; Sedaghat S; Ikram MK; Waziry R; Koudstaal W; Klap J; Kostense S; Hofman A; Anderson R; Goudsmit J; Ikram MA
    Brain; 2020 Apr; 143(4):1220-1232. PubMed ID: 32206776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble CD14 in cerebrospinal fluid is associated with markers of inflammation and axonal damage in untreated HIV-infected patients: a retrospective cross-sectional study.
    Jespersen S; Pedersen KK; Anesten B; Zetterberg H; Fuchs D; Gisslén M; Hagberg L; Trøseid M; Nielsen SD
    BMC Infect Dis; 2016 Apr; 16():176. PubMed ID: 27103116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.